Stability of a trivalent recombinant protein vaccine formulation against botulinum neurotoxin during storage in aqueous solution
about
Vaccines with aluminum-containing adjuvants: optimizing vaccine efficacy and thermal stabilityCurrent status and future directions of botulinum neurotoxins for targeting pain processingIn Vivo Synthesis of Cyclic-di-GMP Using a Recombinant Adenovirus Preferentially Improves Adaptive Immune Responses against Extracellular Antigens.Structural and immunological analysis of anthrax recombinant protective antigen adsorbed to aluminum hydroxide adjuvant.Working together: interactions between vaccine antigens and adjuvants.The importance of interfaces in protein drug delivery - why is protein adsorption of interest in pharmaceutical formulations?Physicochemical and functional characterization of vaccine antigens and adjuvants.Particulate inorganic adjuvants: recent developments and future outlook.The mechanisms of action of vaccines containing aluminum adjuvants: an in vitro vs in vivo paradigm.Mechanism of immunopotentiation and safety of aluminum adjuvants.The role of adjuvant in mediating antigen structure and stability.The immunogenicity of thin-film freeze-dried, aluminum salt-adjuvanted vaccine when exposed to different temperatures.Unraveling the enigma: elucidating the relationship between the physicochemical properties of aluminium-based adjuvants and their immunological mechanisms of action
P2860
Q24634332-7C42AB3D-9DCD-48F3-B3A0-556B4F9E1C58Q26778129-8D5C174B-F9F1-4FA2-AB9F-2F2299D5286FQ33924419-5BA30AB7-1224-48AD-86AD-3F5F892FBB4CQ34344419-A01C5D30-40FB-43C5-9D5A-7A1C94B1393BQ37668409-40F13884-9CF2-4AAE-9892-955B96A00891Q37873947-4363584A-1ADF-4E6A-BD01-4610C3644018Q38202170-B4802446-9EDF-4593-867F-CBF7DB53BD18Q38286377-BC6C06F2-1988-4FB6-8CB8-AE067702638BQ38453147-87215FFE-04C9-415D-8816-5BFD9B10A0FDQ42036323-EF3559C6-A0D4-4131-8088-D721940383C6Q43934225-37D31307-E590-4760-B34C-C08B636AD698Q47121608-B335202F-44EE-4CF9-B13D-AD7F34C01433Q59137099-80DF74F3-AF55-412E-8B5D-FF86E1657C52
P2860
Stability of a trivalent recombinant protein vaccine formulation against botulinum neurotoxin during storage in aqueous solution
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Stability of a trivalent recom ...... ng storage in aqueous solution
@ast
Stability of a trivalent recom ...... ng storage in aqueous solution
@en
type
label
Stability of a trivalent recom ...... ng storage in aqueous solution
@ast
Stability of a trivalent recom ...... ng storage in aqueous solution
@en
prefLabel
Stability of a trivalent recom ...... ng storage in aqueous solution
@ast
Stability of a trivalent recom ...... ng storage in aqueous solution
@en
P2093
P2860
P356
P1476
Stability of a trivalent recom ...... ng storage in aqueous solution
@en
P2093
Christina Vessely
Ian Henderson
John F Carpenter
Julianne Cooper
Latoya Jones Braun
Rajiv Nayar
Theodore W Randolph
P2860
P304
P356
10.1002/JPS.21498
P407
P577
2009-09-01T00:00:00Z